Clinical trial
Treatment of Wegener's Granulomatosis With Cyclophosphamide
NCT00001155 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00001155 |
|---|---|
| Title | Treatment of Wegener's Granulomatosis With Cyclophosphamide |
| Official title | Treatment of Wegener's Granulomatosis With Cyclophosphamide |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Vasculitis, Wegener's Granulomatosis |
| Intervention type | Drug |
| Interventions | cyclophosphamide |
| Enrollment | 200 |
| Start date | Feb 1, 1976 |
| Completion | Feb 1, 2002 |
| First posted | Nov 4, 1999 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: